About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Minoxidil Response Testing in Males With Androgenetic Alopecia

NCT02198261·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Applied Biology, Inc.

Age

18–49

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Males in overall good health
Age: 18 to 49
Diagnosed with male androgenetic alopecia with vertex pattern IIIv, IV, or V on the Norwood Hamilton Scale
Willing to have a mini dot tattoo placed in the target area of the scalp
Willing to maintain the same hair style, color, shampoo and hair products use, and approximate hair length throughout the study
Able to give informed consent
Able to comply with the study requirements for 16 consecutive weeks

You may not be if

Previous adverse event from topical minoxidil treatment
Does not use and have not used in the past 6 months anti-androgen therapy such as finasteride
Does not use and have not used in the past 6 months minoxidil (topical or oral)
Does not take medication known to cause hair thinning such as Coumadin and anti-depressants/anti-psychotics
Folliculitis
Scalp psoriasis
Seborrheic dermatitis
Inflammatory scalp conditions such as lichen planopilaris

The record

StatusCompleted

PhaseNo phase

Taking part300

StartedJul 2014

UpdatedOct 5, 2018

Conditions

Androgenetic Alopecia

Where5

Physicians Hair Institute
Tucson, Arizona, United States
Tennessee Clinical Research Center
Nashville, Tennessee, United States
Sinclair Dermatology
East Melbourne, Australia

Clareo Health | Minoxidil Response Testing in Males With Androgenetic Alopecia